Home/Filings/4/0000899243-19-013259
4//SEC Filing

OSHEA WILLIAM J 4

Accession 0000899243-19-013259

CIK 0001563880other

Filed

May 12, 8:00 PM ET

Accepted

May 13, 5:02 PM ET

Size

9.4 KB

Accession

0000899243-19-013259

Insider Transaction Report

Form 4
Period: 2019-05-09
Transactions
  • Conversion

    Series A Preferred Stock

    2019-05-09307,6070 total
    Common Stock (43,127 underlying)
  • Conversion

    Series C Preferred Stock

    2019-05-09478,9510 total
    Common Stock (55,919 underlying)
  • Conversion

    Common Stock

    2019-05-09+99,046114,080 total
Footnotes (2)
  • [F1]On May 9, 2019, the Series A Preferred Stock, and the dividends that had accrued thereon to date, converted into Common Stock on a 9.5-for-one basis without payment of further consideration automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
  • [F2]On May 9, 2019, the Series C Preferred Stock, and the dividends that had accrued thereon to date, converted into Common Stock on a 9.5-for-one basis without payment of further consideration automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.

Issuer

Trevi Therapeutics, Inc.

CIK 0001563880

Entity typeother

Related Parties

1
  • filerCIK 0001251725

Filing Metadata

Form type
4
Filed
May 12, 8:00 PM ET
Accepted
May 13, 5:02 PM ET
Size
9.4 KB